Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis

Lin Y.-T.Yu C.-L.YU-KANG TUChi C.-C.2022-05-102022-05-1020222227-9059https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128263655&doi=10.3390%2fbiomedicines10040826&partnerID=40&md5=83384ba6617fb6c9549c393ec12bb6c6https://scholars.lib.ntu.edu.tw/handle/123456789/610071[SDGs]SDG3Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysisjournal article10.3390/biomedicines100408262-s2.0-85128263655